Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report
Eur Neuropsychopharmacol. 2026 Jul 17;113:112907. doi: 10.1016/j.euroneuro.2026.112907. Online ahead of print.ABSTRACTEsketamine nasal spray (NS) is an established treatment for patients with treatment resistant depression (TRD)....
